Related references
Note: Only part of the references are listed.VALIDATION AND SIMPLIFICATION OF THE RADIATION THERAPY ONCOLOGY GROUP RECURSIVE PARTITIONING ANALYSIS CLASSIFICATION FOR GLIOBLASTOMA
Jing Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches
Kathryn Beal et al.
RADIATION ONCOLOGY (2011)
FET-PET for malignant glioma treatment planning
Maximilian Niyazi et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Therapeutic options for recurrent malignant glioma
Maximilian Niyazi et al.
RADIOTHERAPY AND ONCOLOGY (2011)
miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival
Lili Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas
Bastian Malzkorn et al.
BRAIN PATHOLOGY (2010)
miR-195, miR-455-3p and miR-10a*are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
Kenta Ujifuku et al.
CANCER LETTERS (2010)
Potential role of miRNAs and their inhibitors in glioma treatment
Kaveh Asadi-Moghaddam et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas
Bronwyn Stall et al.
RADIATION ONCOLOGY (2010)
MicroRNA involvement in glioblastoma pathogenesis
Jana Novakova et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
RADIOGRAPHIC AND HISTOPATHOLOGIC OBSERVATIONS AFTER COMBINED EGFR INHIBITION AND HYPOFRACTIONATED STEREOTACTIC RADIOSURGERY IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS
Amanda L. Schwer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
SAFETY AND EFFICACY OF BEVACIZUMAB WITH HYPOFRACTIONATED STEREOTACTIC IRRADIATION FOR RECURRENT MALIGNANT GLIOMAS
Philip H. Gutin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors
Alfredo Conti et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP53 Mutations in World Health Organization Grade II Gliomas
Niklas Thon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
microRNAs in Gliomas: Small Regulators of a Big Problem
Joachim Silber et al.
NEUROMOLECULAR MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
James W. Welsh et al.
RADIATION ONCOLOGY (2009)
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme - a dosimetric comparison
Marc D. Piroth et al.
RADIATION ONCOLOGY (2009)
A dosimetric comparison of four treatment planning methods for high grade glioma
Leor Zach et al.
RADIATION ONCOLOGY (2009)
Stereotactic radiosurgery for glioblastoma: retrospective analysis
Tithi Biswas et al.
RADIATION ONCOLOGY (2009)
Recurrence pattern after [(18)F]Fluoroethyltyrosine-Positron Emission Tomography-guided radiotherapy for high-grade glioma: A prospective study
Damien C. Weber et al.
RADIOTHERAPY AND ONCOLOGY (2009)
ExacTrac X-ray G degree-of-freedom image-guidance for intracranial non-invasive stereotactic radiotherapy: Comparison with kilo-voltage cone-beam CT
Jinli Ma et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma
Damien C. Weber et al.
RADIATION ONCOLOGY (2008)
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
Eva M. Grasbon-Frodl et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Epidemiology of brain tumors
James L. Fisher et al.
NEUROLOGIC CLINICS (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Extensive modulation of a set of microRNAs in primary glioblastoma
SA Ciafrè et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanisms of translational control by the 3′ UTR in development and differentiation
CH de Moor et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Share Paper
